Chronic stress is epidemic, and it is killing us. We know that and strive to become healthier. For some people that can be ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

The creation of a “Make America Healthy Again Commission” has raised concerns over Washington youths' access to medications ...

If you or a loved one has been diagnosed with schizophrenia, here’s what to know about the causes of cognitive symptoms, their health effects, and how to manage them. “These difficulties could ...

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, discusses the bidirectional relationship between schizophrenia and ...

Ketamine can trigger symptoms similar to those of schizophrenia, but it isn’t known to cause the disorder itself. Ketamine is gaining attention for its potential to treat depression and other ...

Those with the disorder experience symptoms of schizophrenia such as delusions, hallucinations, disorganised speech and cognitive impairment; together with symptoms of disordered mood such as ...

Lexapro (escitalopram) and Zoloft (sertraline) are two prescription medications classified as selective serotonin reuptake inhibitors (SSRIs) used to treat mood disorders, like depression and anxiety.

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of marijuana, a new study says.

Examples of neurotransmitters include serotonin, dopamine, and norepinephrine. There are several types of antidepressants on the market. They all work slightly differently by targeting certain ...

with variants in the serotonin system being implicated in depression and impulsive-aggressive behaviours. Recent reports of rare large chromosomal deletions in autism and schizophrenia suggest ...

OPC-4392 was shown to be effective against negative symptoms and showed no propensity to induce extrapyramidal symptoms in individuals with schizophrenia ... as at novel serotonin receptor ...